The Boston Trust Walden Corp has reportedly sold 171,941 shares of the Waters Corporation. Despite this, Waters Corporation's stock slipped following an acquisition announcement. Notwithstanding, the corporation raised its annual profit forecast due to stronger lab equipment demand. That said, Waters managed to beat Q3 sales expectations and has launched new technology to boost the development of next-generation biotherapeutics. The corporation's strong revenue growth and updated guidance have been highlighted in Q3 and Q2 earnings, respectively. Wells Fargo has also raised its price target for Waters.
Interest in Waters Corporation continues with either acquisition or sale of shares invested by multiple organizations including Voya Investment Management LLC, Thrivent Financial for Lutherans, Oak Thistle LLC, Union Bancaire Privee UBP SA and California Public Employees Retirement System among others. Assenagon Asset Management S.A and Alliancebernstein L.P. too significantly boosted their holdings in Waters Corporation.
In a major undertaking, Waters Corporation has decided to merge with BD Biosciences in a $17.5 billion deal, positioning itself as leader in life science and diagnostics; additionally acquiring Halo Labs. Waters Corporation's near future looks promising with Q4 revenue projections indicating increase and earnings per share growth. The company's India business gets a good boost due to demand for weight loss drugs.
Waters Corp WAT News Analytics from Tue, 04 Mar 2025 08:00:00 GMT to Wed, 31 Dec 2025 17:34:44 GMT - Rating 6 - Innovation 8 - Information 9 - Rumor -1
